Advancing medicines
that matter.
From the first preclinical batch to commercial launch and beyond, Resilience keeps your biologics and sterile drug product programs moving toward the patients who need them.
1
supply chain from thaw to distribution in the greater Cincinnati, Ohio area
220M+
sterile drug product units released
600+
batches executed each year
50+
global markets served
50L - 2,000L
single-use commercial scale bioreactors
1M+
square feet of manufacturing facilities in North America
Built on Experience.
Focused on What's Next.
Resilience is the CDMO partner for biotech and pharma companies at every stage of development and manufacturing.
Our teams bring more than 20 years of expertise across biologics drug substance and sterile drug product, with device assembly, labeling, and packaging capabilities that extend through market-ready finished goods. Across our North American network, experienced teams, advanced technology, and proven manufacturing operations turn promising science into dependable supply. And from day one, we plan for what comes next, giving every program the best chance to become a medicine that matters.
Resilience and Lilly Invest $750 Million to Increase US-Manufactured Medicine Supply
Resilience and Lilly are expanding a partnership that began in 2023. A new $750 million investment grows our Ohio operations and adds KwikPen® device manufacturing.
Find the Right Path for Your Program
Whether you're preparing your first IND or supplying global markets, we match our capabilities and operating model to your stage and scale.
Pharma
Commercial supply you can plan around
From launch onward, you receive high-volume sterile drug product manufacturing for a single product or a full portfolio, with digitally enabled operations that keep supply steady even as demand changes. Our robust quality and regulatory compliance enable seamless development, production, and distribution across North America, the EU, Asia, and the Middle East. Sustainability programs at our sites support the supplier standards your procurement teams track.
Biotech
A CDMO built around your timeline and program
Get direct access to the scientists and quality experts working on your molecule, plus flexible support as you move from early clinical phases to commercial launch. We provide phase-appropriate development and advanced quality systems, ensuring your lead candidate receives the same dedicated technical attention and personalized care as any commercial-scale product.
Not Sure Where to Start?
See our capabilities and sites in one place.
Capabilities for Clinical and Commercial Programs
Start at any phase of your program. Choose drug substance, drug product, or both, whether that means beginning with development and tech transfer, scaling up later, or bringing us material you've already made.
In Ohio, product goes from thaw through filling, inspection, device assembly, and final packaging, ready for distribution. Because we run our services on shared quality systems and dedicated program management, you get consistent standards whichever path you take.
Development
Process, analytical, formulation development, and process characterization, that gets your molecule clinic-ready and set up to scale.
Tech Transfer
A stage-gated transfer process with defined checkpoints, designed to get your process up and running at our sites with speed and consistency.
Biologics Drug Substance
Clinical and commercial production of monoclonal antibodies, recombinant proteins, and other complex molecules in single-use bioreactors up to 2,000L, as well as plasma proteins, transgenics, and other purification programs across a wide range of scales.
Sterile Drug Product
Formulation and aseptic filling of vials, prefilled syringes, and cartridges, from first clinical batches to commercial supply.
Device Assembly, Packaging & Logistics
Autoinjector and prefilled syringe assembly, multiple vial packaging options, plus labeling, serialization, and cold-chain logistics, all at the same site where your product is filled and inspected.
.png?width=2840&height=1704&name=Frame%202147234450%20(1).png)
The Teams Behind Every Program
We bring rigorous quality systems and disciplined execution to each milestone you set.
01
Proven Quality
100% regulatory inspection success rate across our network for more than a decade. Tenured regulatory teams and a robust digital quality management system, rigorously verified and aligned with global inspection requirements (eg. FDA cGMP, FDA pre-approval, Health Canada, PMDA, and EMA inspections, plus EU Annex 1 compliance).
02
Technical Depth
Demonstrated expertise across process and analytical development, formulation, process characterization, technology transfer, and validation. We bring together deep technical knowledge and practical experience to help overcome development challenges, accelerate timelines, and move promising therapies toward the clinic sooner.
03
Reliable Execution
<60 days from formulation to labeled, market-ready units through automation and digital platforms from manufacturing to quality. A program manager and technical lead guide your program through each stage gate, backed by manufacturing and operations teams who deliver on their commitments.
04
Direct Access
15 years average technical and scientific team tenure across our network. Work directly with the scientists and quality leads who know your molecule, and take clear ownership and accountability from start to finish. We use centralized data systems to give you transparent, accurate updates when you ask.
Specialized North American Operations
West Chester, Blue Ash, and Toronto each bring a defined specialty, backed by continued investment in the equipment and automation you rely on.
West Chester, Ohio
Greater Cincinnati, Ohio Area
Our commercially licensed sterile drug product site spans 580,000 square feet. Teams manage everything from formulation to market-ready sterile drug product units through aseptic fill/finish manufacturing, automated visual inspection, device assembly, labeling, and packaging, enabled by digital operations and established sustainability initiatives.
Explore West Chester
Blue Ash, Ohio
Greater Cincinnati, Ohio Area
Home to our global headquarters, this 250,000-square-foot facility specializes in automated visual inspection, device assembly, labeling, packaging, cold storage, and logistics, driven by advanced equipment and dedicated operational teams.
Explore Blue Ash
Toronto, Ontario
Canada
Our biologics hub, a 136,000-square-foot facility, drives process and analytical development, and co-localized drug substance and drug product manufacturing with additional capabilities planned. On-site capabilities include formulation, aseptic fill/finish, cold storage, and comprehensive logistics to support your clinical and commercial programs.
Explore Toronto
The Latest From Resilience
View More InsightsResilience Further Advances North American Manufacturing Strategy Transformation
The Future of CDMOs: Navigating the Combinations Interview with Kothari and Jonathon Amaya-Hodges
On Demand Webinar: Outsourced Pharma Capabilities Update - Large Molecule
Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
Let's Talk About Your Program.
Tell us your stage, timeline, and expected volumes. We'll connect you with the team who will do the work.